BIOMAT Database Logo BIOMAT Database Logo

Dopa-responsive dystonia (Segawa disease) -like disease accompanied by mental retardation: a case report. 2007

Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004421 Dystonia An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77) Muscle Dystonia,Dystonia, Diurnal,Dystonia, Limb,Dystonia, Paroxysmal,Diurnal Dystonia,Dystonia, Muscle,Limb Dystonia,Paroxysmal Dystonia
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson

Related Publications

Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
Dopa-responsive dystonia (Segawa syndrome).
July 2006, Indian pediatrics,
Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
Cases of dopa-responsive dystonia (Segawa disease) in Estonia.
May 2010, Brain & development,
Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
[Dopa-responsive dystonia (Segawa syndrome) with secondary skeleton deformity].
January 2006, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
Motor control in childhood onset dopa-responsive dystonia (Segawa syndrome).
November 1989, Neuropediatrics,
Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
A case report of dopa-responsive dystonia.
June 2001, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
Brief case report: dopa-responsive dystonia.
January 2013, Journal of insurance medicine (New York, N.Y.),
Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
Uneventful electroconvulsive therapy in a patient with dopa-responsive dystonia (Segawa syndrome).
December 2009, The journal of ECT,
Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
Dopa-responsive dystonia of childhood: a case report.
June 1995, Singapore medical journal,
Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
[Segawa's disease: progressive dystonia responsive to L-dopa. A case report].
December 1993, Arquivos de neuro-psiquiatria,
Eiichiro Nagata, and Arifumi Kosakai, and Kortaro Tanaka, and Masaya Segawa, and Hiroki Fujioka, and Haruo Shintaku, and Norihiro Suzuki
Are Dopa-responsive dystonia and Parkinson's disease related disorders? A case report.
June 2012, Parkinsonism & related disorders,
Copied contents to your clipboard!